Utilizing a novel polymer platform for targeted delivery of bacterial metabolites to the gut, ClostraBio is dedicated to treating food allergies and IBD. Our team is breaking new ground in treatments that restore compromised protective intestinal barrier function. We are exploring the therapeutic potential of the bacterial metabolites as treatments for immune-mediated diseases, particularly IBD and food allergy. Visit us at www.clostrabio.com to learn more!